Lynne Sullivan
Director of Finance/CFO presso UNITY BIOTECHNOLOGY, INC.
Patrimonio netto: 59 760 $ in data 31/03/2024
Profilo
Lynne Sullivan is currently serving as a Director at Bioverativ Therapeutics, Inc., Solid Biosciences, Inc., Inozyme Pharma, Inc., BiomX Ltd., Inheris Pharmaceuticals, Inc., and as the CFO & Head-Corporate Development at Unity Biotechnology, Inc. Previously, she held positions as an Independent Director at resTORbio, Inc., Director at KJT Group, Inc., Independent Director at BiomX, Inc., Senior Vice President-Finance at Biogen, Inc., Vice President-Tax at Merck KGaA, Chief Financial Officer at Compass Therapeutics LLC, Vice President-Tax at EMD Serono, Inc., and Tax Partner at Arthur Anderson & Co. Ms. Sullivan obtained a graduate degree from Bentley University in 1990 and an undergraduate degree from Suffolk University in 1987.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
| 11/05/2023 | 33 009 ( 0.20% ) | 54 135 $ | 31/03/2024 | |
BIOMX INC.
0.03% | 25/07/2023 | 12 500 ( 0.03% ) | 5 625 $ | 31/03/2024 |
INOZYME PHARMA, INC.
-.--% | 13/06/2023 | 0 ( -.--% ) | - $ | 31/03/2024 |
SOLID BIOSCIENCES INC.
-.--% | 06/06/2023 | 0 ( -.--% ) | - $ | 31/03/2024 |
Posizioni attive di Lynne Sullivan
| Società | Posizione | Inizio |
|---|---|---|
| SOLID BIOSCIENCES INC. | Director/Board Member | 01/11/2015 |
| INOZYME PHARMA, INC. | Director/Board Member | 01/05/2020 |
| UNITY BIOTECHNOLOGY, INC. | Director of Finance/CFO | 01/08/2020 |
Bioverativ Therapeutics, Inc.
 Bioverativ Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Bioverativ Therapeutics, Inc. develops pharmaceutical products. It develops medicines for chronic diseases such as hemophilia, anemia, multiple sclerosis, and autoimmune disorders. The company is headquartered in Cambridge, MA. | Director/Board Member | - |
BiomX Ltd.
 BiomX Ltd. Pharmaceuticals: MajorHealth Technology BiomX Ltd. engages in the development of customized phage therapies designed to target and destroy harmful bacteria in chronic diseases such as inflammatory bowel disease and colorectalcancer, as well as bacteria that affect the appearance of the skin. The company was founded by Eran Elinav, Timothy K. Lu, and Rotem Sorek on March 3, 2015 and is headquartered in Ness Ziona, Israel. | Director/Board Member | - |
| Inheris Pharmaceuticals, Inc. | Director/Board Member | - |
Precedenti posizioni note di Lynne Sullivan
| Società | Posizione | Fine |
|---|---|---|
| BIOMX INC. | Director/Board Member | 15/03/2024 |
| ADICET BIO, INC. | Director/Board Member | 15/09/2020 |
Compass Therapeutics LLC
 Compass Therapeutics LLC BiotechnologyHealth Technology Compass Therapeutics LLC operates as a healthcare industry focusing on biotechnology. It offers drug discovery, development, biologics, oncology and immuno-oncology. The company was founded by Errik B. Anderson and Thomas J. Schuetz in 2014 and is headquartered in Cambridge, MA. | Director of Finance/CFO | 01/08/2019 |
| ░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Formazione di Lynne Sullivan
| Bentley University | Graduate Degree |
| Suffolk University | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 6 |
|---|---|
| BIOGEN INC. | Health Technology |
| MERCK KGAA | Health Technology |
| UNITY BIOTECHNOLOGY, INC. | Health Technology |
| SOLID BIOSCIENCES INC. | Health Technology |
| INOZYME PHARMA, INC. | Health Technology |
| BIOMX INC. | Health Technology |
| Aziende private | 8 |
|---|---|
Bioverativ Therapeutics, Inc.
Bioverativ Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Bioverativ Therapeutics, Inc. develops pharmaceutical products. It develops medicines for chronic diseases such as hemophilia, anemia, multiple sclerosis, and autoimmune disorders. The company is headquartered in Cambridge, MA. | Health Technology |
Compass Therapeutics LLC
Compass Therapeutics LLC BiotechnologyHealth Technology Compass Therapeutics LLC operates as a healthcare industry focusing on biotechnology. It offers drug discovery, development, biologics, oncology and immuno-oncology. The company was founded by Errik B. Anderson and Thomas J. Schuetz in 2014 and is headquartered in Cambridge, MA. | Health Technology |
EMD Serono, Inc.
 EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | Health Technology |
| Arthur Anderson & Co. | |
BiomX Ltd.
BiomX Ltd. Pharmaceuticals: MajorHealth Technology BiomX Ltd. engages in the development of customized phage therapies designed to target and destroy harmful bacteria in chronic diseases such as inflammatory bowel disease and colorectalcancer, as well as bacteria that affect the appearance of the skin. The company was founded by Eran Elinav, Timothy K. Lu, and Rotem Sorek on March 3, 2015 and is headquartered in Ness Ziona, Israel. | Health Technology |
resTORbio, Inc.
 resTORbio, Inc. BiotechnologyHealth Technology resTORbio, Inc. is a clinical-stage biopharmaceutical company. The firm engages in the development and commercialization of medicines for aging-related diseases and conditions. It offers an immunotherapy under the TORC1 program. The company was founded by Chen Schor and Joan Mannick on July 5, 2016 and is headquartered in Boston, MA. | Health Technology |
| Inheris Pharmaceuticals, Inc. | |
KJT Group, Inc.
 KJT Group, Inc. Miscellaneous Commercial ServicesCommercial Services KJT Group, Inc. is an evidence-based research and consulting firm. The private company is based in Rochester, NY. The company was founded in 2007 by Kenneth Tomaszewski. Michaela Gascon has been the CEO of the company since 2007. | Commercial Services |
- Borsa valori
- Insiders
- Lynne Sullivan
